Kanamycin Concentration Reduction During the VGXI Process
Download White Paper
Kanamycin is widely used as a selection mechanism during production of plasmid DNA for vaccines and gene therapy products. This white paper details how the concentration of Kanamycin is reduced during the VGXI downstream purification process.
The VGXI Website is set to allow the use of cookies. Cookies help us to give you the best experience on our website. By clicking Accept or continuing to use the site, you agree to use our cookies. If you decline we will not track your information but your browsing experience might be limited. Please visit our Terms and Conditions and our Privacy Policy for more information.AcceptDecline